^
    Back
    Association details:
    Biomarker:PDIA3 underexpression
    Cancer:Glioma
    Drug:temozolomide (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    New
    Source:
    Oncol Rep
    Title:

    P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas

    Excerpt:
    High expression of P4HB and PDIA3 is associated with poor survival of glioma patients...high expression of P4HB and PDIA3 is correlated with poor survival outcome of diffuse glioma patients.
    DOI:
    10.3892/or.2017.6134